[OFER-TRABEC] NAC: Sara Borrell - Miguel Servet (type I) candidates

------------------------
¿Necesitas coordinar un grupo de trabajo o proyecto de investigación?

RedIRIS te ofrece de forma gratuita un herramienta sencilla sin
conocimientos informáticos: Listas de distribución
http://www.rediris.es/list/crealist.html
*************************
(c)OFER-TRABEC es un servicio ofrecido por el Centro de Comunicaciones RedIRIS
(Permitida la reproducción siempre que se cite la fuente de este Servicio).
------------------------


---Procedencia:
Institución:IDIBELL
Contacto correo-e:mapujana@iconcologia.net
---
Sara Borrell and Miguel Servet (type I) candidates for Breast Cancer Unit

We seek for excellent and highly motivated postdocs that are willing to compite for a "Sara Borrell" contract and/or "Miguel Servet type I" position within the Breast Cancer and Systems Biology Unit of the Catalan Institute of Oncology IDIBELL.

Please visit the ISCIII web page (http://www.isciii.es/; Programa Estatal de Promoción del Talento y su Empleabilidad) to determine if you are eligible for any of these opportunities.

The ideal candidate should be self-motivated and independent, and have strong academic training in biochemistry and cancer cell biology. Applicants must have first-authored publications in respected journals. The research group is situated within the Catalan Institute of Oncology (Bellvitge Institute for Biomedical Research, IDIBELL). The Institute offers strong interactive environment and various excellent opportunities for collaborative research exists within the institute and the surrounding Hospital area.

Interested applicants are encouraged to apply with an email containing your curriculum vitae and names and contact information of two referees to Miquel Àngel Pujana (email: mapujana@iconcologia.net).

Deadline for applications is 20 June 2013.

----------------
Información complementaria de la oferta:
Deadline for applications is 20 June 2013.

Publications by the group:
Maxwell et al. (2011). Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer. PLoS Biology Nov;9(11):e1001199.
Martrat et al. (2011). Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Research 13(2):R40.
Aguilar et al. (2010). Biological reprogramming in acquired resistance to endocrine treatment of breast cancer. Oncogene 29(45):6071-83.

*************************************************************************
Para darse de baja OFER-TRABEC pinche y envíe:
mailto:OFER-TRABEC-signoff-request@listserv.rediris.es
*************************************************************************